India’s incidence of breast cancer may be less than in developed countries, but its mortality is much more. In adult women of the 30 to 69 age group, this is now one of the top two or three causes of mortality. The introduction in 2017, of universal screening for breast cancer as part of public provision of comprehensive primary health care was a huge and highly welcome step forward. Eight years later, we take stock of where we have reached in implementing this policy and the challenges being faced, and why our understanding of primary health care needs to go far beyond what we offer as primary level health services.
2025
After arduous and prolonged negotiations, a global Pandemic Agreement has finally been adopted at the 78th World Health Assembly. But is this Agreement good enough to avert another pandemic catastrophe? In this conversation we invite Prof. Biswajit Dhar, to help us understand the public health implications of the Agreement in the context of the non-participation of the USA, the weaponisation of tariffs and a changing global economic order. And on what developing countries need to do further…
Despite several recent policy initiatives, access to essential diagnostics remains inadequate across many facilities. As a result, patients continue to face out-of-pocket expenses : time delays and inappropriate care due to limited diagnostic availability in public facilities. In this conversation, we examine the barriers and the lessons learnt from existing models including the PPPs and explore strategies for improvement.
Increasing reports of poor quality of medicines manufactured in India, whether as exports or for domestic consumption, are a matter of great concern. But this crisis should not become an excuse for strengthening corporate monopoly and excessive centralization. In this conversation, we discuss the why and how of designing a regulatory regime in India, that can guarantee quality medicines without any compromise to affordability or public health, not only for India, but for the entire third world.
Private practice by government doctors is wide-spread, but far from universal. Further, even in places where it is allowed, the consequences due to the inevitable conflict of interests varies widely. Ongoing efforts towards mitigation also create differential impact. In this conversation we examine the justifications advanced and the principles that could guide public policy in this regard. We further discuss the various scenarios, and what we can learn from these different scenarios to chart our way forward.